Prescription drug · ANDA
Methimazole NDC 62135-206
Methimazole 10 mg/1 · Tablet · Oral · Chartwell RX, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 62135-206-01 | 6213502060162135020601 | 100 TABLET in 1 BOTTLE (62135-206-01)Marketed from Nov 4, 2021 | |
| 62135-206-18 | 6213502061862135020618 | 180 TABLET in 1 BOTTLE (62135-206-18)Marketed from Nov 4, 2021 | |
| 62135-206-30 | 6213502063062135020630 | 30 TABLET in 1 BOTTLE (62135-206-30)Marketed from Nov 4, 2021 | |
| 62135-206-90 | 6213502069062135020690 | 90 TABLET in 1 BOTTLE (62135-206-90)Marketed from Nov 4, 2021 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Methimazole
- Generic name (nonproprietary)
- methimazole
- Active ingredients
- Methimazole — 10 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Chartwell RX, LLCNDC labeler code 62135
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 040411
- Marketing start
- Listing expires
- Other FDA classes
- Thyroid Hormone Synthesis Inhibitors (Mechanism)
- Identifiers
- Product ID 62135-206_4cb57dfc-1ebf-8510-e063-6294a90a31fcSPL ID 4cb57dfc-1ebf-8510-e063-6294a90a31fcSPL set ID 5b25e346-11b6-44ed-89f9-ab927232ac19RxCUI 197941, 197942UNII 554Z48XN5EUPC 0362135206307, 0362135205904, 0362135205010, 0362135205300, 0362135206901, 0362135205188, 0362135205058, 0362135206185, 0362135206017
- Pharmacologic class
- Thyroid Hormone Synthesis Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N462135020601followed by a unit qualifier and the quantityPackage 62135-0206-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Methimazole tablets, USP are indicated: In patients with Graves’ disease with hyperthyroidism or toxic multinodular goiter for whom surgery or radioactive iodine therapy is not an appropriate treatment option. To ameliorate symptoms of hyperthyroidism in preparation for thyroidectomy or radioactive iodine therapy.
Excerpt only. Read the full label for complete information.
About NDC 62135-206
- What is NDC 62135-206?
- 62135-206 is the product NDC for Methimazole, Methimazole 10 mg/1 tablet, listed with the FDA by Chartwell RX, LLC. It has 4 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Methimazole.
- What is the active ingredient?
- Methimazole.
- Who is the labeler?
- Chartwell RX, LLC, NDC labeler code 62135. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Methimazole?
- 53 other product NDCs are listed under this name. See all Methimazole NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Methimazole products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Methimazole | Methimazole 5 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-4747 | 70518-4747-00 |
| Methimazole | Methimazole 5 mg/1 | TabletOral | AvKARE | 73190-084 | 73190-0084-01 |
| Methimazole | Methimazole 10 mg/1 | TabletOral | AvKARE | 73190-085 | 73190-0085-01 |
| Methimazole | Methimazole 5 mg/1 | TabletOral | AiPing Pharmaceutical, Inc. | 11788-011 | 11788-0011-0111788-0011-05 |
| Methimazole | Methimazole 10 mg/1 | TabletOral | AiPing Pharmaceutical, Inc. | 11788-012 | 11788-0012-0111788-0012-05 |
| Methimazole | Methimazole 10 mg/1 | TabletOral | Preferred Pharmaceuticals Inc. | 68788-4063 | 68788-4063-0168788-4063-03 |
| methimazole | Methimazole 5 mg/1 | TabletOral | Coupler LLC | 67046-1651 | 67046-1651-03 |
| methimazole | Methimazole 10 mg/1 | TabletOral | Coupler LLC | 67046-1652 | 67046-1652-03 |
| Methimazole | Methimazole 5 mg/1 | TabletOral | AvPAK | 50268-495 | 50268-0495-15 |
| Methimazole | Methimazole 10 mg/1 | TabletOral | AvPAK | 50268-496 | 50268-0496-15 |
Other NDCs under ANDA 040411
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Methimazole | Methimazole 5 mg/1 | TabletOral | Chartwell RX, LLC | 62135-205 |